BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of chemotherapy in patients with pulmonary tuberculosis in Uzbekistan]. 1969

Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000636 Aminosalicylic Acids A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. Acids, Aminosalicylic
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Effectiveness of various chemotherapy programs in patients with disseminated destructive pulmonary tuberculosis].
January 1985, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis].
January 1984, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis].
January 1987, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Effectiveness of chemotherapy in patients with newly detected pulmonary tuberculosis and its recurrence].
January 1987, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Ways of increasing chemotherapy effectiveness in pulmonary tuberculosis].
May 1981, Vrachebnoe delo,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis].
January 1986, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Characteristics of chemotherapy of pulmonary tuberculosis and its effectiveness in patients with diabetes mellitus].
January 1991, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[EFFECTIVENESS OF CHEMOTHERAPY IN PATIENTS WITH PULMONARY TUBERCULOSIS WITH VARIOUS COMBINATIONS AND SEQUENCE OF DRUGS].
May 1964, Sovetskaia meditsina,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Effectiveness of various chemotherapy schedules in patients with newly detected limited nondestructive pulmonary tuberculosis].
January 1988, Problemy tuberkuleza,
Sh A Alimov, and M V Abdurashitova, and O O Udrit, and M A Azarnykh, and A Z Bruk
[Chemotherapy in patients with chronic pulmonary tuberculosis].
January 1966, Tuberkuloza,
Copied contents to your clipboard!